ES2173400T3 - Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido. - Google Patents

Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido.

Info

Publication number
ES2173400T3
ES2173400T3 ES97309237T ES97309237T ES2173400T3 ES 2173400 T3 ES2173400 T3 ES 2173400T3 ES 97309237 T ES97309237 T ES 97309237T ES 97309237 T ES97309237 T ES 97309237T ES 2173400 T3 ES2173400 T3 ES 2173400T3
Authority
ES
Spain
Prior art keywords
zinc
amino acid
copper compound
copper
cinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97309237T
Other languages
English (en)
Inventor
John C Godfrey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of ES2173400T3 publication Critical patent/ES2173400T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

SE DESCRIBEN COMPUESTOS PARA USO ORAL QUE CONTIENEN UN COMPUESTO DE ZINC, UN COMPUESTO DE COBRE, UN AMINOACIDO Y UN MATERIAL DE BASE. LOS COMPUESTOS PERMITEN LA LIBERACION LENTA DE IONES DE ZINC TRAS SU DISOLUCION EN LA BOCA PARA OBTENER ASI EFECTOS TERAPEUTICOS BENEFICIOSOS DE LOS IONES DE ZINC. EL COMPUESTO DE COBRE APORTA IONES DE COBRE QUE SIRVEN PARA CONTRARRESTAR UNA GRAN INGESTA DE ZINC TAL COMO SUCEDE DESPUES DEL USO PROLONGADO DEL COMPUESTO. UN COCIENTE MOLAR DE 2 A 20 ENTRE AMINOACIDO Y ZINC Y UN COCIENTE MOLECULAR ENTRE COBRE Y ZINC DEL 0,1 AL 0,01 PROPORCIONA COMPUESTOS CON UN SABOR PALADEABLE Y SIN REGUSTO POSTERIOR INCLUSO TRAS LA INCLUSION DEL COMPUESTO DE COBRE.
ES97309237T 1996-11-18 1997-11-17 Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido. Expired - Lifetime ES2173400T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/751,608 US5897891A (en) 1996-11-18 1996-11-18 Flavorful zinc compositions for oral use incorporating copper

Publications (1)

Publication Number Publication Date
ES2173400T3 true ES2173400T3 (es) 2002-10-16

Family

ID=25022758

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97309237T Expired - Lifetime ES2173400T3 (es) 1996-11-18 1997-11-17 Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido.

Country Status (11)

Country Link
US (1) US5897891A (es)
EP (1) EP0842664B1 (es)
JP (1) JP3224767B2 (es)
AT (1) ATE213418T1 (es)
AU (1) AU722478B2 (es)
BR (1) BR9705484A (es)
CA (1) CA2217768C (es)
DE (1) DE69710557T2 (es)
ES (1) ES2173400T3 (es)
IL (1) IL121895A (es)
ZA (1) ZA978920B (es)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19709304C2 (de) * 1997-03-07 2002-08-14 Suedzucker Ag Verfahren zur Herstellung von Hartkaramellen und Tabletten
US6242019B1 (en) * 1997-08-14 2001-06-05 Warner-Lambert Company Taste modified hard confectionery compositions containing functional ingredients
US6316008B1 (en) * 1998-09-03 2001-11-13 John C. Godfrey Combination of zinc ions and vitamin C and method of making
US6627234B1 (en) 1998-12-15 2003-09-30 Wm. Wrigley Jr. Company Method of producing active agent coated chewing gum products
US6586023B1 (en) 1998-12-15 2003-07-01 Wm. Wrigley Jr. Company Process for controlling release of active agents from a chewing gum coating and product thereof
US7163705B2 (en) * 1998-12-15 2007-01-16 Wm. Wrigley Jr. Company Coated chewing gum product and method of making
US6531114B1 (en) 1999-04-06 2003-03-11 Wm. Wrigley Jr. Company Sildenafil citrate chewing gum formulations and methods of using the same
US6322806B1 (en) 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center
US7935362B2 (en) * 1999-04-06 2011-05-03 Wm. Wrigley Jr. Company Over-coated product including consumable center and medicament
US6426090B1 (en) * 1999-04-06 2002-07-30 Wm. Wrigley Jr. Company Over-coated product including tableted center and medicament
US6773716B2 (en) 1999-04-06 2004-08-10 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US6355265B1 (en) 1999-04-06 2002-03-12 Wm. Wrigley Jr. Company Over-coated chewing gum formulations
US20020159956A1 (en) * 1999-04-06 2002-10-31 Ream Ronald L. Over-coated chewing gum formulations
US6645535B2 (en) 1999-09-02 2003-11-11 Wm. Wrigley Jr. Company Method of making coated chewing gum products containing various antacids
US6663849B1 (en) 2000-09-01 2003-12-16 Wm. Wrigley Jr. Company Antacid chewing gum products coated with high viscosity materials
US6541048B2 (en) 1999-09-02 2003-04-01 Wm. Wrigley Jr. Company Coated chewing gum products containing an acid blocker and process of preparing
US6569472B1 (en) 2000-09-01 2003-05-27 Wm. Wrigley Jr. Company Coated chewing gum products containing antacid and method of making
US9253991B2 (en) 1999-09-20 2016-02-09 Jack Barreca Chewing gum with B vitamins
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
WO2001021147A1 (en) * 1999-09-20 2001-03-29 Mastercare Diet and weight control gum and sucker
US9387168B2 (en) 1999-09-20 2016-07-12 Jack Barreca Chewing gum with tomatidine
DK1220678T3 (da) 1999-10-04 2007-07-09 John Carter Farmaceutiske præparater indeholdende kobber, salicylsyre og C-vitamin
WO2001026665A1 (en) * 1999-10-15 2001-04-19 Bawa Rajan S Liquid nutritional supplement composition and method of preparation
US6436885B2 (en) 2000-01-20 2002-08-20 The Procter & Gamble Company Antimicrobial cleansing compositions containing 2-pyrrolidone-5-carboxylic acid
US6572900B1 (en) 2000-06-09 2003-06-03 Wm. Wrigley, Jr. Company Method for making coated chewing gum products including a high-intensity sweetener
US7115288B2 (en) * 2000-06-09 2006-10-03 Wm. Wrigley Jr. Company Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
US6444241B1 (en) 2000-08-30 2002-09-03 Wm. Wrigley Jr. Company Caffeine coated chewing gum product and process of making
US6579545B2 (en) 2000-12-22 2003-06-17 Wm. Wrigley Jr. Company Coated chewing gum products containing an antigas agent
GB2374008B (en) * 2001-04-04 2005-03-16 John Carter Pharmaceutical compositions comprising copper and zinc
US20040192587A9 (en) * 2002-04-23 2004-09-30 Rosenbloom Richard A. Zinc formulations as a prophylactic treatment for the common cold
JP2004277308A (ja) * 2003-03-13 2004-10-07 Mitsui & Co Ltd 紫外線誘導活性酸素抑制剤
WO2004098571A1 (en) * 2003-04-30 2004-11-18 Zicam, Llc Cold remedy composition comprising zinc salts
EP1617817B1 (en) * 2003-04-30 2007-09-19 Zicam, LLC Oral spray to reduce cold symptoms and duration of same
WO2004098566A2 (en) * 2003-04-30 2004-11-18 Zicam, Llc Chewable lozenge cold remedy composition and method for making same
DE10352129A1 (de) * 2003-11-04 2005-06-16 Grillo Zinkoxid Gmbh Verfahren zur Herstellung einer Organozinkverbindung und deren Verwendung in einer zinkhaltigen Zusammensetzung für die Nahrungsergänzung
JP4261429B2 (ja) * 2004-06-28 2009-04-30 三栄源エフ・エフ・アイ株式会社 食品の呈味改善方法
JP5162812B2 (ja) * 2004-07-08 2013-03-13 大正製薬株式会社 亜鉛含有経口投与用組成物
JP5546089B2 (ja) * 2004-10-04 2014-07-09 大正製薬株式会社 亜鉛化合物配合組成物
WO2006135445A2 (en) * 2004-11-03 2006-12-21 Albion Laboratories, Inc. Antimicrobial chelates
JP2006333802A (ja) * 2005-06-03 2006-12-14 Pola Chem Ind Inc ニキビ用の食品組成物
US8278355B2 (en) 2006-09-12 2012-10-02 Therexcell Pharma Inc. Isovaline for treatment of pain
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
JP2008182948A (ja) * 2007-01-30 2008-08-14 Goshu Yakuhin Kk 亜鉛含有飲料
RU2526199C2 (ru) * 2009-09-29 2014-08-20 Сисейдо Компани, Лтд. Композиция, способствующая выработке коллагена
ES2617492T3 (es) 2012-12-19 2017-06-19 Colgate-Palmolive Company Productos antitranspirantes con proteína y sales antitranspirantes
RU2628540C2 (ru) 2012-12-19 2017-08-18 Колгейт-Палмолив Компани Продукты для ухода за полостью рта, включающие оксид цинка и триметилглицин
JP5968558B2 (ja) 2012-12-19 2016-08-10 コルゲート・パーモリブ・カンパニーＣｏｌｇａｔｅ−Ｐａｌｍｏｌｉｖｅ Ｃｏｍｐａｎｙ 亜鉛リジン錯体
CA2892421C (en) 2012-12-19 2019-10-01 Colgate-Palmolive Company Oral care products comprising a tetrabasic zinc - amino acid - halide complex
MX368740B (es) 2012-12-19 2019-10-14 Colgate Palmolive Co Gel oral que comprende un complejo de zinc - aminoacidos.
US9504858B2 (en) 2012-12-19 2016-11-29 Colgate-Palmolive Company Zinc amino acid halide complex with cysteine
US9498421B2 (en) 2012-12-19 2016-11-22 Colgate-Palmolive Company Two component compositions containing tetrabasic zinc-amino acid halide complexes and cysteine
US10494589B2 (en) 2012-12-19 2019-12-03 Colgate-Palmolive Company Method for indicating time for washing or indicating delivery of antibacterial agent
MX353019B (es) 2012-12-19 2017-12-18 Colgate Palmolive Co Enjuagues bucales de haluros de aminoácidos y zinc.
US9675823B2 (en) 2012-12-19 2017-06-13 Colgate-Palmolive Company Two component compositions containing zinc amino acid halide complexes and cysteine
EP2934438B1 (en) 2012-12-19 2017-02-15 Colgate-Palmolive Company Zinc amino acid/trimethylglycine halide
MX355285B (es) 2012-12-19 2018-04-13 Colgate Palmolive Co Composicion con precursores de haluros de zinc aminoacidos/trimetilglicina.
US9750670B2 (en) 2012-12-19 2017-09-05 Colgate-Palmolive Company Zinc amino acid complex with cysteine
US10188112B2 (en) 2012-12-19 2019-01-29 Colgate-Palmolive Company Personal cleansing compositions containing zinc amino acid/trimethylglycine halide
US9861563B2 (en) 2012-12-19 2018-01-09 Colgate-Palmolive Company Oral care products comprising tetrabasic zinc chloride and trimethylglycine
CA2896569C (en) 2012-12-19 2020-03-24 Colgate-Palmolive Company Oral care compositions comprising zinc amino acid halides
BR112015014444B1 (pt) 2012-12-19 2019-10-01 Colgate-Palmolive Company Uso de um complexo de halogeneto de zinco aminoácido, composição que compreende um complexo de halogeneto de zinco aminoácido e método de limpeza de um dente
US10413570B2 (en) * 2016-12-01 2019-09-17 Daniel McCaughan Method of manufacturing a zinc compound lozenge
CN108383746A (zh) * 2018-04-26 2018-08-10 江西和泽生物科技有限公司 一种甘氨酸锌螯合物的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US33465A (en) * 1861-10-08 Improved steering apparatus
GB2022998B (en) * 1978-06-14 1982-09-08 Beres J Phermaceutical composition for the treatment of neoplasticand other diseases
CA1243952A (en) * 1984-06-11 1988-11-01 John C. Godfrey Flavor of zinc supplements for oral use
US4758439A (en) * 1984-06-11 1988-07-19 Godfrey Science & Design, Inc. Flavor of zinc supplements for oral use
US4837219A (en) * 1987-11-05 1989-06-06 Jeffrey Hutterer Medication for Alzheimer's disease
US5075116A (en) * 1989-04-20 1991-12-24 Lahaye Laboratories, Inc. Composition and method for treatment of macular degeneration
US5132113A (en) * 1990-10-26 1992-07-21 Maurizio Luca Nutritional composition containing essential amino acids
FR2674755B1 (fr) * 1991-04-05 1995-02-03 Thorel Jean Noel Nouvelles compositions medicamenteuses immunostimulatrices.
US5569477A (en) * 1995-04-28 1996-10-29 Mccready Consumer Products, Inc. Chewing gum containing vitamins or other active materials

Also Published As

Publication number Publication date
DE69710557T2 (de) 2002-08-08
JP3224767B2 (ja) 2001-11-05
ZA978920B (en) 1998-04-17
ATE213418T1 (de) 2002-03-15
CA2217768C (en) 2001-02-06
US5897891A (en) 1999-04-27
IL121895A0 (en) 1998-03-10
DE69710557D1 (de) 2002-03-28
EP0842664A1 (en) 1998-05-20
IL121895A (en) 2000-09-28
EP0842664B1 (en) 2002-02-20
AU4525697A (en) 1998-05-21
BR9705484A (pt) 1999-04-06
AU722478B2 (en) 2000-08-03
MX9707902A (es) 1998-08-30
JPH10175870A (ja) 1998-06-30

Similar Documents

Publication Publication Date Title
ES2173400T3 (es) Composiciones que contienen cinc para administracion oral que incluyen un compuesto de cobre y un aminoacido.
DE3787061T2 (de) Chelatierte aminosäurezusammensetzungen zur verabreichung an bestimmte gewebestellen.
DE69305105T3 (de) Zusammensetzungen zur oralen Nahrungsmittelaufnahme mit verbessertem Geschmack
EG26287A (en) Fixed solid composition containing pregabalin, glycol or glycerol as moisturizer
IL115871A (en) Pharmaceutical composition containing a melt-extruded blend of components and a method for the preparation thereof
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
MX9504034A (es) Formas de administracion medicamentosas que contienen acido tioctico, o sales solidas del acido tioctico de liberacion y biodisponibilidad mejoradas.
BR9906920A (pt) "tts contendo um antioxidante"
MY119403A (en) Novel compounds with analgesic effect.
ATE433756T1 (de) Gelierte zusammensetzungen
IL131541A0 (en) A slow release composition
NZ225950A (en) Calcium citrate malate in the molar ratio of 6:2:3; pharmaceutical compositions
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
BR9005010A (pt) Composicao oral
DE69414857T2 (de) Präparat gegen haarausfall und brüchiche nägel
CO4910113A1 (es) Composiciones farmaceuticas estabilizadas, a base de quinu- pristina y de dalfopristina y su preparacion
UA42797C2 (uk) Похідні хінолон- і нафтиридонкарбонової кислоти та похідні ізоіндолу для їх одержання
DK521389D0 (da) Praeparat til behandling af adrenoleukodystrofi
EP0127389A3 (en) N,n-diethyl-5-methyl-2h-1-benzothiopyrano-(4,3,2-cd)-indazole-2-ethanamine, compositions comprising the same and uses therefor
GB9309723D0 (en) Nutritional composition form oral administration to an animal
IL140487A0 (en) Solid compositions suitable for oral administration containing non-hygroscopic salts of l-carnitine and alkanoyl l-carnitines
MXPA01003340A (es) Composiciones farmaceuticas en base a alfa-ciclodextrina para la administracion por via oral de analogos de lh-rh.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 842664

Country of ref document: ES